Evidence map›Paper›PMID 21248167›Full record

ReviewPhysiological reviews2011

Hyaluronan as an immune regulator in human diseases.

Dianhua Jiang, Jiurong Liang, Paul W Noble

Open access · greenAbstract readReview
In one paragraph

Review in Physiological reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 526 papers.

0numbers the graph read from it
0cells of the map it votes in
526citing papers in PubMed
31.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

526 citing papers in PubMed, 1,039 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Naive CD4iScience · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. NFAT1Cellular & molecular biology letters · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

466 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dianhua JiangDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina 27710, USA. dianhua.jiang@duke.edu
Jiurong Liang
Paul W Noble
Duke University · US

Funding

MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASEP50HL084917 · NHLBI · DUKE UNIVERSITY · PI ROCKMAN, HOWARD A · 2006 to 2010
$13.2M
MECHANISMS OF MACROPHAGE ACTIVATION IN LUNG INFLAMMATIONR01HL060539 · NHLBI · YALE UNIVERSITY · PI NOBLE, PAUL WESLEY · 1997 to 2019
$6.5M
Innate Immune Mechanisms of Non-infectious Lung InflammationR01AI052201 · NIAID · YALE UNIVERSITY · PI NOBLE, PAUL WESLEY · 2002 to 2021
$6.4M
Regulation of Pulmonary Fibrosis by CXCR3R01HL077291 · NHLBI · YALE UNIVERSITY · PI NOBLE, PAUL WESLEY · 2005 to 2013
$3.1M
NHLBI NIH HHS P50 HL084917NHLBI NIH HHS P50-HL-84917NHLBI NIH HHS R01 HL060539NHLBI NIH HHS R01 HL077291NHLBI NIH HHS R01-HL-60539NHLBI NIH HHS R01-HL-77291NIAID NIH HHS R01 AI052201NIAID NIH HHS R01-AI-52201
6 · The paper itself

Abstract

Accumulation and turnover of extracellular matrix components are the hallmarks of tissue injury. Fragmented hyaluronan stimulates the expression of inflammatory genes by a variety of immune cells at the injury site. Hyaluronan binds to a number of cell surface proteins on various cell types. Hyaluronan fragments signal through both Toll-like receptor (TLR) 4 and TLR2 as well as CD44 to stimulate inflammatory genes in inflammatory cells. Hyaluronan is also present on the cell surface of epithelial cells and provides protection against tissue damage from the environment by interacting with TLR2 and TLR4. Hyaluronan and hyaluronan-binding proteins regulate inflammation, tissue injury, and repair through regulating inflammatory cell recruitment, release of inflammatory cytokines, and cell migration. This review focuses on the role of hyaluronan as an immune regulator in human diseases.

Indexed as

AnimalsArthritisBrain InjuriesDiabetes MellitusHeart DiseasesHumansHyaluronan ReceptorsHyaluronic AcidHyaluronoglucosaminidaseImmune SystemKidney DiseasesLiver DiseasesLung DiseasesSignal TransductionStem CellsToll-Like ReceptorsHyaluronan ReceptorsHyaluronic AcidHyaluronoglucosaminidaseToll-Like Receptors

Identifiers

PMID21248167
PMCPMC3051404
OpenAlexW2097847761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.